EP3033069A1 - Cleansing wipes - Google Patents
Cleansing wipesInfo
- Publication number
- EP3033069A1 EP3033069A1 EP14749997.4A EP14749997A EP3033069A1 EP 3033069 A1 EP3033069 A1 EP 3033069A1 EP 14749997 A EP14749997 A EP 14749997A EP 3033069 A1 EP3033069 A1 EP 3033069A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- wipe
- skin treatment
- grams
- composition
- polyquaternium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 claims abstract description 152
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 63
- 229920000289 Polyquaternium Polymers 0.000 claims abstract description 27
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 26
- 239000000344 soap Substances 0.000 claims abstract description 24
- 239000004094 surface-active agent Substances 0.000 claims abstract description 21
- 239000003906 humectant Substances 0.000 claims abstract description 17
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960003237 betaine Drugs 0.000 claims abstract description 16
- 150000007524 organic acids Chemical class 0.000 claims abstract description 16
- 239000002738 chelating agent Substances 0.000 claims abstract description 15
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 239000000758 substrate Substances 0.000 claims description 49
- -1 q.s. Substances 0.000 claims description 40
- 239000000470 constituent Substances 0.000 claims description 25
- 230000008901 benefit Effects 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 description 85
- 150000003839 salts Chemical class 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 19
- 238000004140 cleaning Methods 0.000 description 16
- 239000003205 fragrance Substances 0.000 description 16
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 16
- 230000002500 effect on skin Effects 0.000 description 15
- 125000004432 carbon atom Chemical group C* 0.000 description 14
- 239000003960 organic solvent Substances 0.000 description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 13
- 239000003755 preservative agent Substances 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000003002 pH adjusting agent Substances 0.000 description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 230000002335 preservative effect Effects 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 125000000217 alkyl group Chemical group 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 8
- 229960004889 salicylic acid Drugs 0.000 description 8
- 230000000699 topical effect Effects 0.000 description 8
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 7
- 229910052783 alkali metal Inorganic materials 0.000 description 7
- 125000000129 anionic group Chemical group 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- FKKAGFLIPSSCHT-UHFFFAOYSA-N 1-dodecoxydodecane;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC FKKAGFLIPSSCHT-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 230000000845 anti-microbial effect Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 235000005985 organic acids Nutrition 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 4
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 150000001340 alkali metals Chemical class 0.000 description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 4
- 229960001484 edetic acid Drugs 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 150000002191 fatty alcohols Chemical class 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 4
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- 229920002994 synthetic fiber Polymers 0.000 description 4
- 239000012209 synthetic fiber Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 229920001131 Pulp (paper) Polymers 0.000 description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- OUDSFQBUEBFSPS-UHFFFAOYSA-N ethylenediaminetriacetic acid Chemical compound OC(=O)CNCCN(CC(O)=O)CC(O)=O OUDSFQBUEBFSPS-UHFFFAOYSA-N 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000002070 germicidal effect Effects 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- GCICAPWZNUIIDV-UHFFFAOYSA-N lithium magnesium Chemical compound [Li].[Mg] GCICAPWZNUIIDV-UHFFFAOYSA-N 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000008234 soft water Substances 0.000 description 3
- 150000003871 sulfonates Chemical class 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- RAEOEMDZDMCHJA-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-[2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]ethyl]amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CCN(CC(O)=O)CC(O)=O)CC(O)=O RAEOEMDZDMCHJA-UHFFFAOYSA-N 0.000 description 2
- CIEZZGWIJBXOTE-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]propanoic acid Chemical compound OC(=O)C(C)N(CC(O)=O)CC(O)=O CIEZZGWIJBXOTE-UHFFFAOYSA-N 0.000 description 2
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229940120146 EDTMP Drugs 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 238000000222 aromatherapy Methods 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 150000001642 boronic acid derivatives Chemical class 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940051250 hexylene glycol Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000004679 hydroxides Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- JPMIIZHYYWMHDT-UHFFFAOYSA-N octhilinone Chemical compound CCCCCCCCN1SC=CC1=O JPMIIZHYYWMHDT-UHFFFAOYSA-N 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- 229960003330 pentetic acid Drugs 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 150000004760 silicates Chemical class 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- 150000003890 succinate salts Chemical class 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- MHXBHWLGRWOABW-UHFFFAOYSA-N tetradecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC MHXBHWLGRWOABW-UHFFFAOYSA-N 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000004711 α-olefin Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- LEEANUDEDHYDTG-UHFFFAOYSA-N 1,2-dimethoxypropane Chemical compound COCC(C)OC LEEANUDEDHYDTG-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- NWGAAWUUGRXXSC-UHFFFAOYSA-N 1-(2-hydroxypropoxy)propan-2-yl 2-hydroxybenzoate Chemical compound CC(O)COCC(C)OC(=O)C1=CC=CC=C1O NWGAAWUUGRXXSC-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- PQHYOGIRXOKOEJ-UHFFFAOYSA-N 2-(1,2-dicarboxyethylamino)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)NC(C(O)=O)CC(O)=O PQHYOGIRXOKOEJ-UHFFFAOYSA-N 0.000 description 1
- XLJGIXLDEYIALO-UHFFFAOYSA-N 2-(carboxymethylamino)-4-hydroxybutanoic acid Chemical compound OCCC(C(O)=O)NCC(O)=O XLJGIXLDEYIALO-UHFFFAOYSA-N 0.000 description 1
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 1
- XNCSCQSQSGDGES-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(O)=O XNCSCQSQSGDGES-UHFFFAOYSA-N 0.000 description 1
- OBWBSSIUKXEALB-UHFFFAOYSA-N 2-aminoethanol;2-hydroxypropanamide Chemical compound NCCO.CC(O)C(N)=O OBWBSSIUKXEALB-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- FEWFXBUNENSNBQ-UHFFFAOYSA-N 2-hydroxyacrylic acid Chemical compound OC(=C)C(O)=O FEWFXBUNENSNBQ-UHFFFAOYSA-N 0.000 description 1
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- WHBKVWBGTBULQY-UHFFFAOYSA-N 2-propylheptyl octanoate Chemical compound CCCCCCCC(=O)OCC(CCC)CCCCC WHBKVWBGTBULQY-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 1
- LDMRLRNXHLPZJN-UHFFFAOYSA-N 3-propoxypropan-1-ol Chemical compound CCCOCCCO LDMRLRNXHLPZJN-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- RJBSTXIIQYFNPX-UHFFFAOYSA-N 4-methoxy-6-phenyl-1,3,5-triazin-2-amine Chemical compound COC1=NC(N)=NC(C=2C=CC=CC=2)=N1 RJBSTXIIQYFNPX-UHFFFAOYSA-N 0.000 description 1
- VWRHSNKTSSIMGE-UHFFFAOYSA-N 5-ethylsulfanyl-1,3,4-thiadiazol-2-amine Chemical compound CCSC1=NN=C(N)S1 VWRHSNKTSSIMGE-UHFFFAOYSA-N 0.000 description 1
- HOSGXJWQVBHGLT-UHFFFAOYSA-N 6-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical group N1C(=O)CCC2=CC(O)=CC=C21 HOSGXJWQVBHGLT-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000011996 Calamus deerratus Nutrition 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000555678 Citrus unshiu Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000194029 Enterococcus hirae Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- 235000015912 Impatiens biflora Nutrition 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 244000002791 Myrciaria paraensis Species 0.000 description 1
- 235000016392 Myrciaria paraensis Nutrition 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- UULYVBBLIYLRCU-UHFFFAOYSA-N Palmitinsaeure-n-tetradecylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC UULYVBBLIYLRCU-UHFFFAOYSA-N 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- DUFKCOQISQKSAV-UHFFFAOYSA-N Polypropylene glycol (m w 1,200-3,000) Chemical class CC(O)COC(C)CO DUFKCOQISQKSAV-UHFFFAOYSA-N 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- JKCPAFFNQYZVSE-NRXHRRLXSA-J [Na+].[Na+].[Na+].[Na+].C(CN([C@@H](CC(=O)[O-])C(=O)[O-])CC(=O)O)(=O)O.N([C@@H](CC(=O)[O-])C(=O)[O-])(CC(=O)O)CC(=O)O Chemical compound [Na+].[Na+].[Na+].[Na+].C(CN([C@@H](CC(=O)[O-])C(=O)[O-])CC(=O)O)(=O)O.N([C@@H](CC(=O)[O-])C(=O)[O-])(CC(=O)O)CC(=O)O JKCPAFFNQYZVSE-NRXHRRLXSA-J 0.000 description 1
- MLDWGLQSBBCMMO-UHFFFAOYSA-N [Na].[Na].[Na].CNCC(=O)O Chemical compound [Na].[Na].[Na].CNCC(=O)O MLDWGLQSBBCMMO-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DHFCLYNGVLPKPK-UHFFFAOYSA-N acetamide;2-aminoethanol Chemical compound CC(N)=O.NCCO DHFCLYNGVLPKPK-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- AJJJMKBOIAWMBE-UHFFFAOYSA-N acetic acid;propane-1,3-diamine Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCCN AJJJMKBOIAWMBE-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000004645 aluminates Chemical class 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- LHIJANUOQQMGNT-UHFFFAOYSA-N aminoethylethanolamine Chemical compound NCCNCCO LHIJANUOQQMGNT-UHFFFAOYSA-N 0.000 description 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid Chemical class OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- SSJXIUAHEKJCMH-UHFFFAOYSA-N cyclohexane-1,2-diamine Chemical compound NC1CCCCC1N SSJXIUAHEKJCMH-UHFFFAOYSA-N 0.000 description 1
- 150000001934 cyclohexanes Chemical class 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- CNHQWLUGXFIDAT-UHFFFAOYSA-N dioctyl 2-hydroxybutanedioate Chemical compound CCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCC CNHQWLUGXFIDAT-UHFFFAOYSA-N 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- KTPZOWQNYDMKLQ-UHFFFAOYSA-L disodium 2-aminoacetate ethanol Chemical compound [Na+].[Na+].CCO.NCC([O-])=O.NCC([O-])=O KTPZOWQNYDMKLQ-UHFFFAOYSA-L 0.000 description 1
- PFBIJXLFJDWOIQ-UHFFFAOYSA-L disodium 4-(3-carboxylatopropanoyloxyamino)oxy-4-oxobutanoate Chemical compound [Na+].C(CCC(=O)[O-])(=O)ONOC(CCC(=O)[O-])=O.[Na+] PFBIJXLFJDWOIQ-UHFFFAOYSA-L 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 229940052296 esters of benzoic acid for local anesthesia Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940052303 ethers for general anesthesia Drugs 0.000 description 1
- 229940035423 ethyl ether Drugs 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- TZMQHOJDDMFGQX-UHFFFAOYSA-N hexane-1,1,1-triol Chemical compound CCCCCC(O)(O)O TZMQHOJDDMFGQX-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940080260 iminodisuccinate Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000004611 light stabiliser Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000712 poly(acrylamide-co-diallyldimethylammonium chloride) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical class CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- HBPNTDBLHQHPLH-UHFFFAOYSA-N tetradecyl 16-methylheptadecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C HBPNTDBLHQHPLH-UHFFFAOYSA-N 0.000 description 1
- DHZWALZKPWZSMA-UHFFFAOYSA-N tetradecyl oleate Natural products CCCCCCCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC DHZWALZKPWZSMA-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- AGGKEGLBGGJEBZ-UHFFFAOYSA-N tetramethylenedisulfotetramine Chemical compound C1N(S2(=O)=O)CN3S(=O)(=O)N1CN2C3 AGGKEGLBGGJEBZ-UHFFFAOYSA-N 0.000 description 1
- 229940080258 tetrasodium iminodisuccinate Drugs 0.000 description 1
- GYBINGQBXROMRS-UHFFFAOYSA-J tetrasodium;2-(1,2-dicarboxylatoethylamino)butanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC(C([O-])=O)NC(C([O-])=O)CC([O-])=O GYBINGQBXROMRS-UHFFFAOYSA-J 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 229940048081 trisodium ethylenediamine disuccinate Drugs 0.000 description 1
- QEHXDDFROMGLSP-VDBFCSKJSA-K trisodium;(2s)-2-[2-[[(1s)-1-carboxy-2-carboxylatoethyl]amino]ethylamino]butanedioate Chemical compound [Na+].[Na+].[Na+].OC(=O)C[C@@H](C([O-])=O)NCCN[C@H](C([O-])=O)CC([O-])=O QEHXDDFROMGLSP-VDBFCSKJSA-K 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Definitions
- the present invention relates to wipe products which are advantageously used to treat the skin, hair or other dermal surfaces.
- the wipe products are advantageously used in the treatment of hands, face, and/or other parts of the human body.
- bar soaps as well as liquid soaps are widely known and are widely used, the use of such products is often inconvenient.
- the use of such bar soap, or liquid soap products requires that such product be carried by a consumer, used, and any remaining portion of the bar soap or liquid soap composition be either abandoned, stored, or further carried by the consumer after its use.
- typically a consumer or is required to you use such a product without the concurrent advantages of a cleaning implement, or such a cleaning implement, e.g., a wipe article must be either provided by the consumer, or be provided at the point of use of any skin treatment operation.
- consumer products which include a composition which is impregnated within a wipe article.
- Such consumer products typically include a wipe article or other cleaning substrate, and having a high proportion of a treatment composition absorbed or absorbed therein/thereon.
- a high proportion of the treatment composition often results in a wipe article which is difficult to remove from adjacent wipe articles one packaged, and/or which have a undesirable or "slimy" feel after their withdrawn from the package. Such discourage the use of many such wipe products in that they are unpleasant to initially handle.
- the relatively higher proportion of the treatment composition if first applied to the hands, parts of body or other dermal surface, also leads to the swift deposition of an often undesirable, slick or film layer upon a treated surface, e.g, dermal surface.
- the present invention comprises a cleansing wipe article having adsorbed thereon and/or absorbed within the a wipe substate a skin treatment composition which comprises (or consists essentially of, or consists of) a composition which includes:
- Polyquaternium material selected from Polyquaternium 7, and/or Polyquaternium 10;
- constituents are compounds which provide a further technical and/or aesthetic benefits to the soap bars
- the relative mass of the skin treatment composition is about 0.5 - 20 grams (preferably about 5 grams) per gram of dry wipe substrate, and/or is about 15 - 650 grams (preferably about 160 grams) of the skin treatment composition per square meter of the wipe substrate.
- the present invention provides a method for the treatment of dermal surfaces, which method comprises the step of:
- a vendible product which comprises: a package or container, preferably which is in the form of a dispensing package or container which includes a resealable opening therein, and one or more, but preferably a plurality of cleansing wipe articles as described herein.
- the cleansing wipe articles comprise a skin treatment composition which is absorbed, or absorbed, therein/thereupon.
- the skin treatment composition necessarily comprises 0.01 - 7%wt. of an anionic surfactant and/or a soap.
- the at least one anionic surfactant may be water soluble anionic sulfonate surfactants and include, but are not limited to: linear C8-C24 alkyl benzene sulfonates; C8-C24 paraffin sulfonates, alpha olefin sulfonates containing about 8 to about 24 carbon atoms and C8-C24 alkyl sulfates and mixtures thereof.
- anionic surfactants may be present as water soluble or water dispersible salts, e.g., alkali metal or alkaline earth metal salts, such as sodium, potassium, ammonium, lithium magnesium as well as alkanolammonium salts of any of these aforementioned compounds.
- alkali metal or alkaline earth metal salts such as sodium, potassium, ammonium, lithium magnesium as well as alkanolammonium salts of any of these aforementioned compounds.
- the anionic surfactant may be any of the anionic surfactants known or previously used in the art of aqueous surfactant compositions. Suitable anionic surfactants include, but are not limited to: alkyl sulfates, alkyl ether sulfates, alkaryl sulfonates, alkyl succinates, alkyl sulfosuccinates, N-alkoyl sarcosinates, alkyl phosphates, alkyl ether phosphates, alkyl ether carboxylates, alkylamino acids, alkyl peptides, alkoyl taurates, carboxylic acids, acyl and alkyl glutamates, alkyl isethionates, and alpha-olefin sulfonates, especially their sodium, potassium, magnesium, ammonium and mono-, di- and triethanolamine salts.
- the alkyl groups generally contain about 8 to about 24 carbon atoms and may be unsaturated.
- These anionic surfactants may be provided as salts of one of these aforementioned compounds, which salts may render them, or improve their solubility or miscibility in water.
- Non-limiting examples of water soluble or water dispersible salts include alkali metal or alkaline earth metal salts, such as sodium, potassium, ammonium, lithium magnesium as well as alkanolammonium salts.
- the anionic surfactant(s) predominantly consist of one or more alkyl alkoxylated ether sulfates, e.g., alkyl ethoxylated ether sulfates or salt form thereof.
- alkyl alkoxylated ether sulfates e.g., alkyl ethoxylated ether sulfates or salt form thereof.
- x has a value of from 1 - 22 inclusive, but preferably has a value of 1 - 10 inclusive
- R is an alkyl group having 8 - 18 carbon atoms
- M is a radical or cation which renders the compound water soluble or water miscible, e.g.,
- anionic surfactants may be provided as salts of one of these aforementioned compounds, which salts may render them, or improve their solubility or miscibility in water.
- water soluble or water dispersible salts include alkali metal or alkaline earth metal salts, such as sodium, potassium, ammonium, lithium magnesium as well as alkanolammonium salts.
- such one or more alkyl ethoxylated ether sulfates or salt form thereof comprise at least 51%, and in order of increasing preference, comprise 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, and especially preferably 100% (wt% or mol%) of the anionic surfactants present in the skin treatment composition.
- An exemplary and preferred anionic surfactant is an alkoxylated lauryl ether sulfate, which is the predominant anionic surfactant present in the treatment
- the alkoxylated lauryl ether sulfate surfactant comprises at least 50.1% (%wt. or %mol) but preferably (in order of increasing preference) at least 55, 60, 65, 70, 75, 80, 85, 90, 95, 97.5, 98, 90.5, 99, 90.5%. of the total amount of the anionic surfactant(s) present in the compositions.
- the alkoxylated lauryl ether sulfate surfactant is the sole anionic surfactant present in the treatment compositions.
- the lauryl ether sulfate surfactant may be provided as a water soluble or water miscible salt, preferably as an alkali metal salt, such as a sodium, or potassium salt.
- a particularly preferred anionic surfactant is a lauryl ether sulfate commercially available as Texapon® N70 (ex. BASF) which is described to be sodium laureth sulfate (2 mols EO), alternately known as sodium poly oxy ethylene lauryl ether sulfate.
- the skin treatment compositions may include an anionic soap.
- anionic soap i.e. alkali metal salts, e.g., sodium or potassium salts
- fatty acids typically having from about 8 to about 24 carbon atoms, preferably from about 10 to about 20 carbon atoms.
- suitable soaps include alkali metal, ammonium and alkanolammonium salts of aliphatic alkane or alkene monocarboxylic acids having about 8 to about 18 carbon atoms.
- Sodium, potassium, ammonium, mono-, di-, and triethanolammonium cations or combinations thereof, are preferred.
- the fatty acids used in making the soaps can be obtained from natural sources such as, for instance, plant or animal-derived glycerides (e.g., palm oil, coconut oil, soybean oil, castor oil, tallow, lard, etc.).
- plant or animal-derived glycerides e.g., palm oil, coconut oil, soybean oil, castor oil, tallow, lard, etc.
- the fatty acids can also be synthetically prepared. Soaps may be prepared by either direct saponification of fats and oils or by neutralization of free fatty acids.
- One or more such anionic soaps may be used in the skin treatment compositions.
- mixtures of one or more of the recited anionic surfactants with one or more of the recited anionic soaps may be used in the skin treatment compositions described herein.
- the skin treatment composition also necessarily comprises 0.1 - 7%wt. of a betaine surfactant which is, preferably selected from water dispersible and water soluble betaine surfactants.
- a betaine surfactant which is, preferably selected from water dispersible and water soluble betaine surfactants.
- Exemplary betaine surfactants include those which may be represented by the general formula:
- Ri is an alkyl group containing from 8 to 18 carbon atoms, or the amido radical which may be represented by the following general formula:
- water-soluble betaine surfactants include dodecyl dimethyl betaine, cocoamidopropyl betaine as well as cocoamidopropyl dimethyl betaine, the latter of which is particularly preferred.
- cocoamidopropyl dimethyl betaine is particularly preferred and in specific especially preferred embodiments is the sole betaine surfactant present in the inventive compositions.
- the skin treatment composition further necessarily comprises 0.1 - 2%wt. of a
- Polyquaternium material selected from Polyquaternium 7, and/or Polyquaternium 10.
- the former material, Polyquaternium 7, is poly(acrylamide-co-diallyldimethylammonium chloride) while the latter material,
- Polyquaternium 10 are polymeric quaternary ammonium salts derived from the reaction of hydroxyethyl cellulose with a
- the skin treatment composition also necessarily includes 0.01 - 0.4%wt. of an antimicrobially effective amount of an organic acid.
- organic acids are those which generally include at least one carbon atom, and include at least one carboxyl group (--COOH) in its structure and which provide an antimicrobial benefit to the skin treatment compositions and/or the cleaning wipe articles. Derivatives of said organic acids are also contemplated to be useful. Of course mixtures of one or more acids are contemplated as being useful.
- Exemplary organic acid include linear aliphatic acids such as acetic acid; dicarboxylic acids, acidic amino acids, and hydroxy acids such as glycolic acid, lactic acid, hydroxyacrylic acid, alpha-hydroxybutyric acid, glyceric acid, malic acid, tartaric acid and citric acid, as well as acid salts of these organic acids.
- salicylic acid derivatives such as esters of salicylic acid, such as ethylhexyl salicylate, dipropylene glycol salicylate, TEA salicylate, salicylic acid 2-ethylhexylester, salicylic acid 4-isopropyl benzylester, salicylic acid homomenthylester are preferred.
- Preferred antimicrobially effective organic acids include lactic acid, salicylic acid and citric acid and/or derivatives thereof; particularly preferred of these are salicylic acid as well as salicylic acid and salicylate esters, including octyl, amyl, phenyl, benzyl, menthyl, glyceryl, and dipropyleneglycol esters.
- salicylic acid as well as salicylic acid and salicylate esters, including octyl, amyl, phenyl, benzyl, menthyl, glyceryl, and dipropyleneglycol esters.
- the skin treatment composition necessarily comprises 0.01 - 2%wt. of a humectant.
- Preferred humectants include sorbitol, hydroxypropyl sorbitol, erythritol, threitol, pentaerythritol, xylitol, glucitol, mannitol, hexylene glycol, butylene glycol (e.g., 1,3-butylene glycol), hexane triol (e.g., 1,2,6-hexanetriol), glycerine, ethoxylated glycerine and propoxylated glycerine.
- humectants include sodium 2- pyrrolidone-5-carboxylate, guanidine; glycolic acid and glycolate salts (e.g. ammonium and quaternary alkyl ammonium); aloe vera in any of its variety of forms (e.g., aloe vera gel); hyaluronic acid and derivatives thereof (e.g., salt derivatives such as sodium hyaluronate); lactamide monoethanolamine; acetamide monoethanolamine; urea; and, panthenol.
- glycolic acid and glycolate salts e.g. ammonium and quaternary alkyl ammonium
- aloe vera in any of its variety of forms (e.g., aloe vera gel); hyaluronic acid and derivatives thereof (e.g., salt derivatives such as sodium hyaluronate); lactamide monoethanolamine; acetamide monoethanolamine; urea; and, panthenol.
- Further exemplary hydrocarbons which may also serve as humectants are those having hydrocarbon chains anywhere from 12 to 30 carbon atoms, particularly, mineral oil, petroleum jelly, squalene and isoparaffins.
- Particularly preferred polyols useful as humectants are glycerine, glycerol, sorbitol and their mixtures. Glycerine and glycerol are particularly preferred for their use as humectants.
- Preferred humectants and preferred weights and/or weight ranges of humectants are described with reference to one or more of the
- the skin treatment composition necessarily further comprises 0.01 - 0.5%wt. of a chelating agent.
- a chelating agent may also provide a pH adjusting or pH buffering benefit as well.
- exemplary useful chelating agents include those known to the art, including by way of non-limiting example; aminopolycarboxylic acids and salts thereof wherein the amino nitrogen has attached thereto two or more substituent groups.
- Useful chelating agents include one or more of ethylene diamine tetra acetic acid (EDTA), diethylene triamine penta acetic acid (DTP A), ethane-1 -hydroxy-1 ,1 - diphosphonate (EHDP), ethylene diamine- ⁇ , ⁇ '-disuccinate (EDDS), nitrilo triacetic Acid (NTA), sodium imino disuccinate (IDS), ethylene glycol-bis-(2-aminoethyl)- ⁇ , ⁇ , ⁇ ', N'-tetra acetic acid (EGTA), methyl glycine diacetic acid (MGDA), N-(2- hydroxyethyl) ethylene diamine ⁇ , ⁇ ', ⁇ '-thacetic acid) (HEDTA), ethylene diamine tetra methylene phosphonic acid (EDTMP), diethylene thamine-penta-methylene phosphonic acid (DTPMP), glutamic acid-N,N-diacetic acid (
- succinates e.g., trisodium ethylene diamine disuccinate, tetra-sodium imino disuccinate, glutamic acid- ⁇ , ⁇ diacetic acid tetra sodium salt, 2-hydroxyethyl iminodiacetic acid, sodium salt (disodium ethanol diglycinate), tetrasodium 3- hydroxy-2,2 imino
- chelating agents include acids and salts, especially the sodium and potassium salts of ethylenediaminetetraacetic acid,
- diethylenetriaminepentaacetic acid N-hydroxyethylethylenediaminetriacetic acid, and of which the sodium salts of ethylenediaminetetraacetic acid may be particularly
- Such particularly preferred chelating agents are highly effective, available low-cost, and are generally mild to the skin and other topical surfaces.
- the final essential constituent of the skin treatment compositions is water.
- Water comprises at least 70% wt, preferably at least 75%wt. of the skin treatment
- the water may be from any suitable source including available tap water such as from a municipal water supply, reservoir or well, as well as deionized, demineralized, or distilled water. Deionized, demineralized, or distilled water a particularly preferred as reducing the quantity of undesirable impurities which may be present
- the water is provided in quantum sufficient ("q.s.") in order to provide 100%wt. of the skin treatment composition. It is to be understood that a major proportion of the water initially present in the skin treatment compositions is driven off or otherwise removed during the manufacture of the cleansing wipe articles of the invention.
- the skin treatment compositions may optionally comprise, as a cumulative total, up to 5%wt. of one or more further compositions, constituents are compounds which provide a further technical and/or aesthetic benefits to the cleansing wipe articles disclosed herein. Such differ from the foregoing essential constituents.
- Such optional constituents include additives and adjuvants which are conventional in the cosmetic, pharmaceutical or dermatological field, such as further surfactants other than those listed as essential constituents, emulsifiers, emollients, skin conditioning agents, preservatives, antioxidants, solvents especially organic solvents, pH adjusting agents, pH buffers, chelating agents, fragrances or other materials which provide an aromatherapy benefit, fillers, preservatives, dyestuffs or colorants, opacifiers, as well as light stabilizers including UV absorbers.
- the skin treatment compositions may include one or more further anionic, nonionic, cationic, amphoteric or zwitterionic surfactants in addition to those disclosed above as essential constituents.
- the skin treatment compositions of the invention may optionally comprise one or more emollients which provide softness to the largely aqueous topical antimicrobial cleaning compositions.
- emollients include those, for example, compounds based on Guerbet alcohols based on fatty alcohols containing 6 to 18 and preferably 8 to 10 carbon atoms and other additional esters, such as myristyl myristate, myristyl palmitate, myristyl stearate, myristyl isostearate, myristyl oleate, and the like, esters of Cis-38 alkyl-hydroxycarboxylic acids with linear or branched C 6 -22 fatty alcohols, more especially dioctyl malate, esters of linear and/or branched fatty acids with polyhydric alcohols (for example propylene glycol, dimer diol or trimer triol), triglycerides based on Cs-io fatty acids, liquid mono-
- the skin treatment compositions of the invention may include one or more organic solvents, (although in certain particularly preferred embodiments, organic solvents are expressly excluded.)
- organic solvents which may be included in the inventive compositions include those which are at least partially water-miscible such as alcohols (e.g., low molecular weight alcohols, such as, for example, ethanol, propanol, isopropanol, and the like), glycols (such as, for example, ethylene glycol, propylene glycol, hexylene glycol, and the like), water-miscible ethers (e.g.
- diethylene glycol diethylether diethylene glycol dimethylether, propylene glycol dimethylether
- water-miscible glycol ether e.g. propylene glycol monomethylether, propylene glycol mono ethylether, propylene glycol monopropylether, propylene glycol monobutylether, ethylene glycol monobutylether, dipropylene glycol monomethylether, diethyleneglycol monobutylether
- lower esters of monoalkylethers of ethylene glycol or propylene glycol e.g. propylene glycol monomethyl ether acetate
- One preferred optional constituent is a preservative constituent.
- exemplary useful preservatives include compositions which include parabens, including methyl parabens and ethyl parabens, glutaraldehyde, formaldehyde, 2-bromo-2-nitropropoane-l,3-diol, 5- chloro-2-methyl-4-isothiazolin-3-one, 2-methyl-4-isothiazoline-3-one, and mixtures thereof.
- One exemplary composition is a combination 5-chloro-2-methyl-4-isothiazolin- 3 -one and 2-m ethyl -4-isothiazolin-3 -one where the amount of either component may be present in the mixture anywhere from 0.001 to 99.99 weight percent, based on the total amount of the preservative.
- the most preferred preservative are those commercially available preservative comprising a mixture of 5-chloro-2- methyl-4-isothiazolin-3-one and 2-m ethyl -4-isothiazolin-3 -one marketed under the trademark KATHON® CG/ICP as a preservative composition presently commercially available from Rohm and Haas (Philadelphia, PA).
- preservative compositions include KATHON® CG/ICP II, a further preservative composition presently commercially available from Rohm and Haas (Philadelphia, PA), PROXEL® which is presently commercially available from Zeneca Biocides (Wilmington, DE), SUTTOCIDE® A which is presently commercially available from Sutton Laboratories (Chatam, NJ) as well as TEXTAMER® 38 AD which is presently commercially available from Calgon Corp. (Pittsburgh, PA).
- the optional preservative constituent should not exceed about 3%wt. of the skin treatment composition, although generally lesser amounts are usually effective.
- the skin treatment compositions may include a fragrance constituent, which may be based on natural and synthetic fragrances and most commonly are mixtures or blends of a plurality of such fragrances, optionally in conjunction with a carrier such as an organic solvent or a mixture of organic solvents in which the fragrances are dissolved, suspended or dispersed.
- a fragrance constituent may be present in any effective amount such that it can be discerned by a consumer of the cleansing wipes, however is advantageously present in amounts of up to about 5%wt, preferably from about 0.00001%wt. to about 1.5%wt, most preferably from about
- the skin treatment compositions may include one or more colorants, e.g, dyes or pigments which are known to the art be useful in cosmetic or topical compositions which may be used to impart a desired color or tint to the inventive skin treatment compositions.
- colorants may be present in any effective amount such that it can be discerned by a consumer of the cleansing wipes, however is advantageously present in amounts of up to about 1.5%wt, preferably from about 0.00001%wt. to about 1.0%wt of
- Further optional constituents which may be advantageously included in the skin treatment composition is a pH adjusting agent, which may be used to adjust, and/or buffer the pH of the skin treatment composition.
- any material which may increase or decrease the pH of the skin treatment composition is suitable as a pH adjusting agent.
- pH adjusting agents are one or more acids and/or bases whether such be based on organic and/or inorganic compounds or materials.
- pH adjusting agents include phosphorus containing compounds, monovalent and polyvalent salts such as of silicates, carbonates, and borates, certain acids and bases, tartrates and certain acetates.
- Further exemplary pH adjusting agents include mineral acids, basic compositions, and organic acids, which are typically required in only minor amounts.
- Further exemplary and useful pH adjusting agents include monoalkanolamines, dialkanolamines, trialkanolamines, and alkylalkanolamines such as alkyl- dialkanolamines, and dialkyl-monoalkanolamines.
- alkanol and alkyl groups are generally short to medium chain length, that is, from 1 to 7 carbons in length.
- pH buffering agents also include the alkali metal phosphates, polyphosphates,
- pyrophosphates triphosphates, tetraphosphates, silicates, metasilicates, polysilicates, carbonates, hydroxides, and mixtures of the same.
- Certain salts such as the alkaline earth phosphates, carbonates, hydroxides, can also function as buffers. It may also be suitable to use as buffers such materials as aluminosilicates (zeolites), borates, aluminates and certain organic materials such as gluconates, succinates, maleates, citrates, and their alkali metal salts. It is to be noted that certain of the pH adjusting agents may also provide a chelating benefit as well.
- the one or more optional pH adjusting agents/pH buffers are included in amounts which are effective in establishing and/or maintaining the pH of a skin treatment composition at or within a desired pH value or range of pH values.
- the pH of the skin treatment composition is in the range of 4 - 9.5.
- the one or more pH adjusting agents comprise from about 0.001 - 2.5%wt, preferably from about 0.01 - 1.5%wt. of the skin treatment composition of which the one or more pH adjusting agents form a part.
- a further optional constituent of the invention is a fragrance.
- Fragrances may be based on natural and synthetic fragrances and most commonly are mixtures or blends of a plurality of such fragrances, optionally in conjunction with a carrier such as an organic solvent or a mixture of organic solvents in which the fragrances are dissolved, suspended or dispersed.
- the fragrance constituent may be present in any effective amount such that it can be discerned by a consumer of the cleansing wipe, however is advantageously present in amounts of up to about 5%wt, preferably from about 0.00001%wt. to about 1.5%wt. of the skin treatment composition.
- the skin treatment composition may further include one or more skin benefit agents which may be used to promote an improved skin feel, or to improve skin health or appearance.
- skin benefit agents include but are not limited to lipids such as cholesterol, ceramides, and pseudoceramides; sunscreens such as cinnamates; exfoliant particles such as polyethylene beads, walnut shells, apricot seeds, flower petals and seeds, and inorganics such as silica, and pumice; additional emollients (skin softening agents) such as long chain alcohols and waxes e.g., lanolin; additional moisturizers; skin-toning agents; skin nutrients such as vitamins like Vitamin C, D and E and essential oils like bergamot, citrus unshiu, calamus, and the like; water soluble or insoluble extracts of avocado, grape, grape seed, myrrh, cucumber, watercress, calendula, elder flower, geranium, linden blossom, amaranth, seaweed, gingko, gins
- materials identified as examples of humectants, or as carriers for fragrances, essential oils or other optional constituents are not considered to fall within the class of excluded organic solvents.
- the skin treatment compositions include not more than 0.5%wt, and in order of increasing preference, not more than 0.4%, 0.3%, 0.25%, 0.2% 0.15% 0.1%, 0.09%, 0.08%, 0.07%, 0.06%, 0.05%, 0.04%, 0.03%, 0.025%, 0.02%, 0.01%, 0.005%, 0.001%, and especially not more than 0% of said volatile organic solvents.
- the skin treatment compositions are absorbed and/or absorbed onto a dry wipe substrate, and thereafter, a major proportion the water present in the skin treatment compositions is withdrawn, such as by evaporation, gentle heating, suction, or other operation, thereby retaining the remaining constituents having a vapor pressure greater than that of the water, at the conditions at which the water is withdrawn, absorbed/absorbed upon or within the substrate.
- a dry wipe substrate preferably has a moisture content of less than 10% wt, more preferably less than 5%wt, prior to the application of the skin treatment compositions thereto.
- the skin treatment composition Preferably during manufacture, after application of the skin treatment composition to a dry wipe, at least about 75%, and in order of increasing preference, at least about 80%,, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 99.5%, 99.5% of the water initially present in the skin treatment composition is removed.
- the relative mass of the foregoing skin treatment composition prior to the removal of a major proportion (e.g. >90%, more preferably > 95%) of the water is about 0.5 - 20 grams (preferably about 5 grams) per gram of dry wipe substrate to which the skin treatment composition is applied.
- the skin treatment compositions is about 0.015 - 0.75 grams, preferably 2 - 5.5 grams of the treatment composition per gram of the dry wipe substrate.
- suitable substrates include, without limitation: sponges, wipe articles, towels, cloths, pads and the like.
- Wipe articles can be of a woven or non-woven nature.
- Fabric substrates can include nonwoven or woven pouches, sponges, in the form of abrasive or non-abrasive cleaning pads.
- Such fabrics are known commercially in this field, and are generally substantially planar. Frequently, individual pieces of such fabrics are often referred to as wipes.
- wipe articles are substantially planar in configuration, and have a thickness which is much less (generally at least 10 times less, preferably at least 100 times less) then the length and/or width of the wipe article. As such, such generally planar wipe articles are typically considered to be substantially "two-dimensional" type articles.
- wipes may be provided as individual sheets which are provided as an individual article, or a plurality of folded wipes, or as a web of individual separable wipes joined at regions or lines of perforations and supplied upon a roll and whereby, an individual wipe can be separated from the roll by tearing along such a line of perforations.
- wipes can be resin bonded, hydroentanged, thermally bonded, meltblown, needlepunched or any combination of the former.
- Nonwoven fabrics may be a combination of wood pulp fibers and textile length synthetic fibers formed by well known dry-form or wet-lay processes. Synthetic fibers such as rayon, nylon, orlon and polyester as well as blends thereof can be employed.
- the wood pulp fibers should comprise about 30 to about 60 percent by weight of the nonwoven fabric, preferably about 55 to about 60 percent by weight, the remainder being synthetic fibers.
- the wood pulp fibers provide for absorbency, abrasion and soil retention whereas the synthetic fibers provide for substrate strength and resiliency.
- the cleansing wipe articles of the invention initially appear to be substantially dry to the touch when provided to the consumer and thereby, the undesirable initial "slimy" feel prevalent among many known-art consumer products is avoided.
- the wipe articles in the invention can be used to provide a useful skin treatment benefit using little, or no water added to the wipe article and/or applied to a hands or other dermal surfaces to which the wipe article is thereafter contacted, such provides for a much greater degree of control by the consumer utilizing the cleaning wipe article of the delivery of the skin treatment composition. Such is advantageous particularly where a source of available water to subsequently used to rinse the hand or other dermal surfaces is unavailable, or available only in limited quantities.
- the resultant cleansing wipes retain a smooth, slightly damp tactile feel and may be used even in the absence of additional water, or rinse water.
- a small amounts, or even greater amount of water is applied to wets the hands, or other dermal surfaces prior to, but preferably during the use of the cleansing wipe article in order to express a satisfactory amount of foam or lather on to the treated dermal surfaces.
- such also aids in the release of the antimicrobially effective amount of an organic acid from the cleansing wipe, and thereby an effective
- antimicrobial effect is imparted to the treated dermal surfaces.
- the wipe articles may be used to provide a treatment benefit to a human or other mammalian body, preferably hands, face, and/or other parts of the human body, e.g, epidermis, and hair.
- treatment benefits include one or more of: a cleaning benefit, topical application of the skin treatment composition provided by the wipe article to a dermal surface and/or hair, and/or an antimicrobial benefit.
- a further aspect of the invention is a method for providing a cleaning and/or providing an germicidal benefit to skin or other topical surface which method
- a germicidal benefit is provided to the skin or other topical surface to which has been applied a treatment composition present upon on within a wipe article or other substrate.
- Preferred embodiments of the largely aqueous topical antimicrobial cleaning compositions exhibit good germicidal efficacy of undesired microorganisms, such as gram positive and/or gram negative bacterial, e.g., S.aureus, E.coli, P.auruginosa, as well as E.hirae on dermal (viz., skin, body) surfaces.
- Cleansing wipes according to the invention can be produced by first producing a suitable quantity of a skin treatment composition, which is thereafter applied to a suitable substrate, most preferably a wipe to thereafter absorb, and/or adsorb the skin treatment composition within and/or upon said wipe.
- a role of a substrate is used to produce a plurality of wipes simultaneously.
- the use of a roll substrate also provides for use of known equipment, processes whereby the liquid skin treatment composition is introduced to the wipe substrate.
- a quantity of the skin treatment composition can be applied by spraying, dipping, padding, rolling, partially immersing, or holy immersing the wipe substrate within the skin treatment composition.
- a series of pinch rollers can be used to squeeze the thus treated wipes substrate, in order to limit the amount of the liquid skin treatment composition absorbed and/or absorbed. Thereafter, a major portion of the water is removed, and such is most advantageously inconveniently performed by passing the treated substrate over one or more heated rollers whereby the substrate is in contact for a sufficient amount of time whereby at least 75%wt, preferably, at least 80%, and more preferably about 85%wt. of the water present in the skin treatment compositions is withdrawn or removed, such as by evaporation. Removal of the water can be further facilitated by including auxiliary equipment which may be fans, blowers, which may optionally provide further air streams to the wipe substrate being treated, in order to accelerate the removal of water.
- the skin treatment composition of the cleansing wipe article comprises (or consists essentially of, or consists of) :
- constituents are compounds which provide a further technical and/or aesthetic benefits to the composition
- the said composition having a pH in the range of 4 - 9, and
- the relative mass of the foregoing composition is 0.015 - 0.75 grams, preferably 0.12 - 0.175 grams per gram of dry wipe substrate, and/or 0.5 - 25 grams, preferably 2 - 5.5 grams of the foregoing composition per square meter of a wipe substrate.
- One or more cleansing wipe articles may be provided in a suitable package, or the cleansing wipes can be used individually without a package.
- a single cleansing wipe or a plurality of cleansing wipes may be provided, and such one or more wipes can be withdrawn as desired by a consumer or other ultimate user from the package and ultimately used to treat a dermal surface.
- the package may be a single use package, such as a pouch's physical integrity is destroyed upon opening, or may be a resealable package, or by following the removal of one or more wipes, package can be resealed to isolate the remaining cleansing wipes within the package from the surrounding environment.
- Such packaged cleansing wipe articles provide embodiments of the vendible articles of the invention.
- Example compositions according to the invention are identified on Table 1.
- the identified constituents were used "as supplied” from their respective suppliers, which are identified on Table 1, and may have constitute less than 100%wt. "actives” or may have been supplied constituting 100% wt. "active” of the named compound, as indicated below.
- Polyquaternium-7 polymeric quaternary ammonium salt of
- citric acid (anhydrous) technical grade, anhydrous citric acid (100%wt.
- ethylenediaminetetraacetic acid (87%wt. actives) fragrance used as supplied, proprietary composition of its supplier
- Cleansing wipes were produced by applying 8.03 grams of the composition described on Table 1 to a dry wipe nonwoven substrate material ("N Grade #180710, ex. Ahlstrom Co.) at an initial loading of 8.03 grams the skin treatment composition was applied to the said dry wipe substrate, yielding 160.5 grams the skin treatment composition per square meter of wipe substrate.
- the thus treated substrate was subjected to a drying process, wherein either the substrate loaded with the skin treatment composition is allowed to air dry to remove most of the water initially present, or the thus treated substrate passes over or under a drying station, e.g, one or more heated rollers which induce the removal of most of the water initially present, or other processing equipment, e.g, infrared heaters, microwave heaters, which are similarly effective in removing most of the water initially present in the skin treatment composition loaded onto the dry wipe nonwoven substrate material.
- a drying station e.g, one or more heated rollers which induce the removal of most of the water initially present
- other processing equipment e.g, infrared heaters, microwave heaters
- the thus manufactured cleansing wipe articles may be retained in a continuous roll form, or may be perforated at one or more regions thereof, or may be cut into individual sheets which facilitate their use.
- the cleansing wipe articles may optionally but preferably be packaged so that a plurality of wipe articles are provided in a container as a vendible product, which allows for one or more of the wipe articles to be withdrawn from the package and used, as desired by a consumer.
- the manufactured cleansing wipe articles were tested by rinsing with a small amount of water to wet the article, and thereafter the wipe article was applied to the hands in a wiping manner to release the constituents of the resultant skin treatment composition onto the skin to provide a cleaning benefit thereto.
- the cleansing wipe articles initially appeared to be substantially dry to the touch and did not have an initial "slimy" feel. Good foaming and effective cleaning of the hands was observed when used.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Detergent Compositions (AREA)
- Cosmetics (AREA)
Abstract
Cleansing wipes comprising a composition comprising an anionic surfactant and/or a soap, a betaine surfactant, polyquaternium (7) and/or polyquaternium (10), an antimicrobially effect amount of an organic acid, a humectant and a chelating agent. A method of manufacturing a cleansing wipe comprises preparing a first wipe then removing a major proportion of water present to obtain a second wipe. Wipe articles may be obtained that do not have an undesirable or slimy feel on removal from their package.
Description
CLEANSING WIPES
The present invention relates to wipe products which are advantageously used to treat the skin, hair or other dermal surfaces. In a preferred method of use the wipe products are advantageously used in the treatment of hands, face, and/or other parts of the human body.
While the use of bar soaps, as well as liquid soaps are widely known and are widely used, the use of such products is often inconvenient. The use of such bar soap, or liquid soap products requires that such product be carried by a consumer, used, and any remaining portion of the bar soap or liquid soap composition be either abandoned, stored, or further carried by the consumer after its use. Also, typically a consumer or is required to you use such a product without the concurrent advantages of a cleaning implement, or such a cleaning implement, e.g., a wipe article must be either provided by the consumer, or be provided at the point of use of any skin treatment operation. Also known to the art are consumer products which include a composition which is impregnated within a wipe article. Such consumer products typically include a wipe article or other cleaning substrate, and having a high proportion of a treatment composition absorbed or absorbed therein/thereon. Disadvantageously, such a high proportion of the treatment composition often results in a wipe article which is difficult to remove from adjacent wipe articles one packaged, and/or which have a undesirable or "slimy" feel after their withdrawn from the package. Such discourage the use of many such wipe products in that they are unpleasant to initially handle. Additionally, the relatively higher proportion of the treatment composition if first applied to the hands, parts of body or other dermal surface, also leads to the swift deposition of an often undesirable, slick or film layer upon a treated surface, e.g, dermal surface. Such is undesirable, particularly if applied to the hands which thereafter are used to activate a source of rinse water, i.e., a faucet which diminishes the grip, and also leaves an undesired, film layer upon a faucet, or other water dispensing apparatus. After multiple uses, such deposits upon faucets or other water dispensing
apparatus leave an unsightly build-up and additionally, typically attract dust from the ambient environment, further worsening the overall appearance of a faucet or other water dispensing apparatus. While such might be easily cleaned off, consumers typically are not in the habit of wiping down faucets, or other water dispensing apparatus after each use of such a cleaning article, and again rinsing their hands or other dermal surfaces.
Thus, notwithstanding the plethora available consumer products, there is still a need for improvements in wipe products which are advantageously used in the treatment of hands, face, and/or other parts of the human body.
In a preferred aspect the present invention comprises a cleansing wipe article having adsorbed thereon and/or absorbed within the a wipe substate a skin treatment composition which comprises (or consists essentially of, or consists of) a composition which includes:
0.01 - 7%wt. of an anionic surfactant and/or a soap;
0.1 - 7%wt. of a betaine surfactant;
0.01 - 2%wt. of a Polyquaternium material selected from Polyquaternium 7, and/or Polyquaternium 10;
0.01 - 0.4%wt. of an antimicrobially effective amount of an organic acid;
0.01 - 2%wt. of a humectant;
0.01 - 0.5%wt. of a chelating agent;
0 - 25%wt. of one or more further compositions, constituents are compounds which provide a further technical and/or aesthetic benefits to the soap bars,
q.s., water,
which foregoing skin treatment composition is absorbed or adsorbed into or onto the wipe substrate, wherein the relative mass of the skin treatment composition is about 0.5 - 20 grams (preferably about 5 grams) per gram of dry wipe substrate, and/or is about 15 - 650 grams (preferably about 160 grams) of the skin treatment composition per square meter of the wipe substrate.
In another aspect, the present invention provides a method for the treatment of dermal surfaces, which method comprises the step of:
dispensing a quantity of a skin treatment composition from a wipe article having absorbed therein and/or absorbed thereon the said skin treatment composition onto a
dermal surface in order to provide a cleaning and/or skin treatment and/or antimicrobial benefit to the treated dermal surface.
In a further aspect there is provided a vendible product which comprises: a package or container, preferably which is in the form of a dispensing package or container which includes a resealable opening therein, and one or more, but preferably a plurality of cleansing wipe articles as described herein.
In a still further aspect there is provided a method for the manufacture of a cleansing wipe article as disclosed herein, as well as manufacture of a vendible product comprising one or more cleansing wipe articles as described herein.
These and further aspects of the invention will become more apparent from a further consideration of the following specification.
The cleansing wipe articles comprise a skin treatment composition which is absorbed, or absorbed, therein/thereupon.
The skin treatment composition necessarily comprises 0.01 - 7%wt. of an anionic surfactant and/or a soap. The at least one anionic surfactant may be water soluble anionic sulfonate surfactants and include, but are not limited to: linear C8-C24 alkyl benzene sulfonates; C8-C24 paraffin sulfonates, alpha olefin sulfonates containing about 8 to about 24 carbon atoms and C8-C24 alkyl sulfates and mixtures thereof. These anionic surfactants may be present as water soluble or water dispersible salts, e.g., alkali metal or alkaline earth metal salts, such as sodium, potassium, ammonium, lithium magnesium as well as alkanolammonium salts of any of these aforementioned compounds.
The anionic surfactant may be any of the anionic surfactants known or previously used in the art of aqueous surfactant compositions. Suitable anionic surfactants include, but are not limited to: alkyl sulfates, alkyl ether sulfates, alkaryl sulfonates, alkyl succinates, alkyl sulfosuccinates, N-alkoyl sarcosinates, alkyl phosphates, alkyl ether phosphates, alkyl ether carboxylates, alkylamino acids, alkyl peptides, alkoyl taurates, carboxylic acids, acyl and alkyl glutamates, alkyl isethionates, and alpha-olefin sulfonates, especially their sodium, potassium, magnesium, ammonium and mono-, di- and triethanolamine salts. The alkyl groups generally contain about 8 to about 24 carbon atoms and may be unsaturated. These anionic surfactants may be provided as salts of one of these aforementioned compounds, which salts may render them, or improve their
solubility or miscibility in water. Non-limiting examples of water soluble or water dispersible salts include alkali metal or alkaline earth metal salts, such as sodium, potassium, ammonium, lithium magnesium as well as alkanolammonium salts.
In certain preferred embodiments, the anionic surfactant(s) predominantly consist of one or more alkyl alkoxylated ether sulfates, e.g., alkyl ethoxylated ether sulfates or salt form thereof. Such compounds include those which may be represented by either of the following formula I and II as follows:
in which formulae, x has a value of from 1 - 22 inclusive, but preferably has a value of 1 - 10 inclusive, R is an alkyl group having 8 - 18 carbon atoms, and M is a radical or cation which renders the compound water soluble or water miscible, e.g., These anionic surfactants may be provided as salts of one of these aforementioned compounds, which salts may render them, or improve their solubility or miscibility in water. Non-limiting examples of water soluble or water dispersible salts include alkali metal or alkaline earth metal salts, such as sodium, potassium, ammonium, lithium magnesium as well as alkanolammonium salts. Preferably such one or more alkyl ethoxylated ether sulfates or salt form thereof comprise at least 51%, and in order of increasing preference, comprise 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, and especially preferably 100% (wt% or mol%) of the anionic surfactants present in the skin treatment composition.
An exemplary and preferred anionic surfactant is an alkoxylated lauryl ether sulfate, which is the predominant anionic surfactant present in the treatment
compositions. Ideally, the alkoxylated lauryl ether sulfate surfactant comprises at least
50.1% (%wt. or %mol) but preferably (in order of increasing preference) at least 55, 60, 65, 70, 75, 80, 85, 90, 95, 97.5, 98, 90.5, 99, 90.5%. of the total amount of the anionic surfactant(s) present in the compositions. Most preferably, the alkoxylated lauryl ether sulfate surfactant is the sole anionic surfactant present in the treatment compositions. The lauryl ether sulfate surfactant may be provided as a water soluble or water miscible salt, preferably as an alkali metal salt, such as a sodium, or potassium salt. A particularly preferred anionic surfactant is a lauryl ether sulfate commercially available as Texapon® N70 (ex. BASF) which is described to be sodium laureth sulfate (2 mols EO), alternately known as sodium poly oxy ethylene lauryl ether sulfate.
In place or, or in addition to the recited anionic surfactants, the skin treatment compositions may include an anionic soap. Such are typically anionic materials (i.e. alkali metal salts, e.g., sodium or potassium salts) of fatty acids, typically having from about 8 to about 24 carbon atoms, preferably from about 10 to about 20 carbon atoms. Further suitable soaps include alkali metal, ammonium and alkanolammonium salts of aliphatic alkane or alkene monocarboxylic acids having about 8 to about 18 carbon atoms. Sodium, potassium, ammonium, mono-, di-, and triethanolammonium cations or combinations thereof, are preferred. The fatty acids used in making the soaps can be obtained from natural sources such as, for instance, plant or animal-derived glycerides (e.g., palm oil, coconut oil, soybean oil, castor oil, tallow, lard, etc.). The fatty acids can also be synthetically prepared. Soaps may be prepared by either direct saponification of fats and oils or by neutralization of free fatty acids. Particularly useful are the sodium, potassium, ammonium and alkanolammonium salts of lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, ricinoleic acid, coconut fatty acid, palm kernel fatty acid and tallow fatty acid, as well as technical grade mixtures thereof. One or more such anionic soaps may be used in the skin treatment compositions. Additionally mixtures of one or more of the recited anionic surfactants with one or more of the recited anionic soaps may be used in the skin treatment compositions described herein.
The identity of preferred anionic surfactants and/or anionic soaps, and the preferred weights thereof are described with reference to one or more of the following examples.
The skin treatment composition also necessarily comprises 0.1 - 7%wt. of a betaine surfactant which is, preferably selected from water dispersible and water soluble betaine surfactants. Exemplary betaine surfactants include those which may be represented by the general formula:
CH3
Rf— N-R2-COCT
I
CH3
wherein Ri is an alkyl group containing from 8 to 18 carbon atoms, or the amido radical which may be represented by the following general formula:
0 H
1 I
R— C-N— (CH2)a- wherein R is an alkyl group having from 8 to 18 carbon atoms, a is an integer having a value of from 1 to 4 inclusive, and R2 is a C1-C4 alkylene group. Examples of such water-soluble betaine surfactants include dodecyl dimethyl betaine, cocoamidopropyl betaine as well as cocoamidopropyl dimethyl betaine, the latter of which is particularly preferred. In certain preferred embodiments, cocoamidopropyl dimethyl betaine is particularly preferred and in specific especially preferred embodiments is the sole betaine surfactant present in the inventive compositions.
The identity of preferred betaine surfactants, and the preferred weights of the betaine surfactants are described with reference to one or more of the following examples.
The skin treatment composition further necessarily comprises 0.1 - 2%wt. of a
Polyquaternium material selected from Polyquaternium 7, and/or Polyquaternium 10. The former material, Polyquaternium 7, is poly(acrylamide-co-diallyldimethylammonium chloride) while the latter material, Polyquaternium 10 are polymeric quaternary ammonium salts derived from the reaction of hydroxyethyl cellulose with a
trimethylammonium substituted epoxide (alternately, Cellulose, 2-(2-hydroxy-3- (trimethylammonium)propoxy)ethyl ether, chloride). Both Polyquaternium 7, and
Polyquaternium 10, are commercially available and are know to be cationic compounds. The preferred weights of the Polyquaternioum materials are described with reference to one or more of the following examples.
The skin treatment composition also necessarily includes 0.01 - 0.4%wt. of an antimicrobially effective amount of an organic acid. Exemplary organic acids are those which generally include at least one carbon atom, and include at least one carboxyl group (--COOH) in its structure and which provide an antimicrobial benefit to the skin treatment compositions and/or the cleaning wipe articles. Derivatives of said organic acids are also contemplated to be useful. Of course mixtures of one or more acids are contemplated as being useful. Exemplary organic acid include linear aliphatic acids such as acetic acid; dicarboxylic acids, acidic amino acids, and hydroxy acids such as glycolic acid, lactic acid, hydroxyacrylic acid, alpha-hydroxybutyric acid, glyceric acid, malic acid, tartaric acid and citric acid, as well as acid salts of these organic acids. Of these, citric acid, sorbic acid, acetic acid, boric acid, formic acid, maleic acid, adipic acid, lactic acid, malic acid, malonic acid, glycolic acid, salicylic acid and/or derivatives thereof, e.g., salicylic acid derivatives such as esters of salicylic acid, such as ethylhexyl salicylate, dipropylene glycol salicylate, TEA salicylate, salicylic acid 2-ethylhexylester, salicylic acid 4-isopropyl benzylester, salicylic acid homomenthylester are preferred. Preferred antimicrobially effective organic acids include lactic acid, salicylic acid and citric acid and/or derivatives thereof; particularly preferred of these are salicylic acid as well as salicylic acid and salicylate esters, including octyl, amyl, phenyl, benzyl, menthyl, glyceryl, and dipropyleneglycol esters. The specific identity of preferred antimicrobially effective organic acids and preferred weights and/or weight ranges thereof are described with reference to one or more of the following examples.
The skin treatment composition necessarily comprises 0.01 - 2%wt. of a humectant. Preferred humectants include sorbitol, hydroxypropyl sorbitol, erythritol, threitol, pentaerythritol, xylitol, glucitol, mannitol, hexylene glycol, butylene glycol (e.g., 1,3-butylene glycol), hexane triol (e.g., 1,2,6-hexanetriol), glycerine, ethoxylated glycerine and propoxylated glycerine. Further useful humectants include sodium 2- pyrrolidone-5-carboxylate, guanidine; glycolic acid and glycolate salts (e.g. ammonium and quaternary alkyl ammonium); aloe vera in any of its variety of forms (e.g., aloe vera
gel); hyaluronic acid and derivatives thereof (e.g., salt derivatives such as sodium hyaluronate); lactamide monoethanolamine; acetamide monoethanolamine; urea; and, panthenol. Still further humectants include polyols e.g., linear and branched chain alkyl polyhydroxyl compounds having a boiling point of at least 120°C, preferably at least 140°C and yet more preferably at least 155°C at 760 mm Hg (= 1 atmosphere) such as: propylene glycol, polyethylene glycol, glycerine and sorbitol. Further exemplary hydrocarbons which may also serve as humectants are those having hydrocarbon chains anywhere from 12 to 30 carbon atoms, particularly, mineral oil, petroleum jelly, squalene and isoparaffins. Particularly preferred polyols useful as humectants are glycerine, glycerol, sorbitol and their mixtures. Glycerine and glycerol are particularly preferred for their use as humectants. Preferred humectants and preferred weights and/or weight ranges of humectants are described with reference to one or more of the following examples.
The skin treatment composition necessarily further comprises 0.01 - 0.5%wt. of a chelating agent. Certain of these chelating agents may also provide a pH adjusting or pH buffering benefit as well. Exemplary useful chelating agents include those known to the art, including by way of non-limiting example; aminopolycarboxylic acids and salts thereof wherein the amino nitrogen has attached thereto two or more substituent groups. Useful chelating agents include one or more of ethylene diamine tetra acetic acid (EDTA), diethylene triamine penta acetic acid (DTP A), ethane-1 -hydroxy-1 ,1 - diphosphonate (EHDP), ethylene diamine- Ν,Ν'-disuccinate (EDDS), nitrilo triacetic Acid (NTA), sodium imino disuccinate (IDS), ethylene glycol-bis-(2-aminoethyl)- Ν,Ν,Ν', N'-tetra acetic acid (EGTA), methyl glycine diacetic acid (MGDA), N-(2- hydroxyethyl) ethylene diamine Ν,Ν',Ν'-thacetic acid) (HEDTA), ethylene diamine tetra methylene phosphonic acid (EDTMP), diethylene thamine-penta-methylene phosphonic acid (DTPMP), glutamic acid-N,N-diacetic acid (GLDA), cyclohexane-1 ,2-diamine- Ν,Ν,Ν',Ν'-tetra-acetic acid (CDTA), 1 ,3- propylenediamine tetra acetic Acid (PDTA), ethylene diamine triacetic acid (EDTA), L-hydroxy imino disuccinic acid (L-IDS), trisodium N-carboxyethyl imino succinate (CEIS), sodium tripolyphosphate (STP), thethylene tetramine hexaacetic acid (TTHA). Other preferred chelating agents are succinates, e.g., trisodium ethylene diamine disuccinate, tetra-sodium imino disuccinate,
glutamic acid-Ν,Ν diacetic acid tetra sodium salt, 2-hydroxyethyl iminodiacetic acid, sodium salt (disodium ethanol diglycinate), tetrasodium 3- hydroxy-2,2 imino
disuccinate, trisodium methylglycine diacetic acid, L- aspartate-N,N-diacetic acid tetrasodium salt. Particularly preferred chelating agents include acids and salts, especially the sodium and potassium salts of ethylenediaminetetraacetic acid,
diethylenetriaminepentaacetic acid, N-hydroxyethylethylenediaminetriacetic acid, and of which the sodium salts of ethylenediaminetetraacetic acid may be particularly
advantageously used. Such particularly preferred chelating agents are highly effective, available low-cost, and are generally mild to the skin and other topical surfaces.
The final essential constituent of the skin treatment compositions is water. Water comprises at least 70% wt, preferably at least 75%wt. of the skin treatment
compositions. The water may be from any suitable source including available tap water such as from a municipal water supply, reservoir or well, as well as deionized, demineralized, or distilled water. Deionized, demineralized, or distilled water a particularly preferred as reducing the quantity of undesirable impurities which may be present The water is provided in quantum sufficient ("q.s.") in order to provide 100%wt. of the skin treatment composition. It is to be understood that a major proportion of the water initially present in the skin treatment compositions is driven off or otherwise removed during the manufacture of the cleansing wipe articles of the invention.
The skin treatment compositions may optionally comprise, as a cumulative total, up to 5%wt. of one or more further compositions, constituents are compounds which provide a further technical and/or aesthetic benefits to the cleansing wipe articles disclosed herein. Such differ from the foregoing essential constituents. Such optional constituents include additives and adjuvants which are conventional in the cosmetic, pharmaceutical or dermatological field, such as further surfactants other than those listed as essential constituents, emulsifiers, emollients, skin conditioning agents, preservatives, antioxidants, solvents especially organic solvents, pH adjusting agents, pH buffers, chelating agents, fragrances or other materials which provide an aromatherapy benefit, fillers, preservatives, dyestuffs or colorants, opacifiers, as well as light stabilizers including UV absorbers.
Optionally the skin treatment compositions may include one or more further anionic, nonionic, cationic, amphoteric or zwitterionic surfactants in addition to those disclosed above as essential constituents.
The skin treatment compositions of the invention may optionally comprise one or more emollients which provide softness to the largely aqueous topical antimicrobial cleaning compositions. Non-limiting examples of useful emollients include those, for example, compounds based on Guerbet alcohols based on fatty alcohols containing 6 to 18 and preferably 8 to 10 carbon atoms and other additional esters, such as myristyl myristate, myristyl palmitate, myristyl stearate, myristyl isostearate, myristyl oleate, and the like, esters of Cis-38 alkyl-hydroxycarboxylic acids with linear or branched C6-22 fatty alcohols, more especially dioctyl malate, esters of linear and/or branched fatty acids with polyhydric alcohols (for example propylene glycol, dimer diol or trimer triol), triglycerides based on Cs-io fatty acids, liquid mono-, di- and triglyceride mixtures based on C6-i8 fatty acids, esters of C6-22 fatty alcohols and/or Guerbet alcohols with aromatic carboxylic acids, more particularly benzoic acid, esters of C2-12 dicarboxylic acids with polyols containing 2 to 10 carbon atoms and 2 to 6 hydroxyl groups, vegetable oils, branched primary alcohols, substituted cyclohexanes, linear and branched C6-22 fatty alcohol carbonates such as, for example, dicaprylyl carbonate (commercially available as Cetiol® CC), Guerbet carbonates based on fatty alcohols containing 6 to 18 and preferably 8 to 10 carbon atoms, esters of benzoic acid with linear and/or branched C6-22 alcohols (for example, a product commercially available as Finsolv® TN), linear or branched, symmetrical or nonsymmetrical dialkyl ethers containing 6 to 22 carbon atoms per alkyl group such as, for example, dicaprylyl ether (commercially available as Cetiol® OE), ring opening products of epoxidized fatty acid esters with polyols and hydrocarbons or mixtures thereof (commercially available as Cetiol® DD), propylheptyl caprylate (commercially available as Cetiol® SenSoft).
Optionally, the skin treatment compositions of the invention may include one or more organic solvents, (although in certain particularly preferred embodiments, organic solvents are expressly excluded.) By way of non-limiting example exemplary organic solvents which may be included in the inventive compositions include those which are at least partially water-miscible such as alcohols (e.g., low molecular weight alcohols, such as,
for example, ethanol, propanol, isopropanol, and the like), glycols (such as, for example, ethylene glycol, propylene glycol, hexylene glycol, and the like), water-miscible ethers (e.g. diethylene glycol diethylether, diethylene glycol dimethylether, propylene glycol dimethylether), water-miscible glycol ether (e.g. propylene glycol monomethylether, propylene glycol mono ethylether, propylene glycol monopropylether, propylene glycol monobutylether, ethylene glycol monobutylether, dipropylene glycol monomethylether, diethyleneglycol monobutylether), lower esters of monoalkylethers of ethylene glycol or propylene glycol (e.g. propylene glycol monomethyl ether acetate), and mixtures thereof.
One preferred optional constituent is a preservative constituent. Exemplary useful preservatives include compositions which include parabens, including methyl parabens and ethyl parabens, glutaraldehyde, formaldehyde, 2-bromo-2-nitropropoane-l,3-diol, 5- chloro-2-methyl-4-isothiazolin-3-one, 2-methyl-4-isothiazoline-3-one, and mixtures thereof. One exemplary composition is a combination 5-chloro-2-methyl-4-isothiazolin- 3 -one and 2-m ethyl -4-isothiazolin-3 -one where the amount of either component may be present in the mixture anywhere from 0.001 to 99.99 weight percent, based on the total amount of the preservative. For reasons of availability, the most preferred preservative are those commercially available preservative comprising a mixture of 5-chloro-2- methyl-4-isothiazolin-3-one and 2-m ethyl -4-isothiazolin-3 -one marketed under the trademark KATHON® CG/ICP as a preservative composition presently commercially available from Rohm and Haas (Philadelphia, PA). Further useful preservative compositions include KATHON® CG/ICP II, a further preservative composition presently commercially available from Rohm and Haas (Philadelphia, PA), PROXEL® which is presently commercially available from Zeneca Biocides (Wilmington, DE), SUTTOCIDE® A which is presently commercially available from Sutton Laboratories (Chatam, NJ) as well as TEXTAMER® 38 AD which is presently commercially available from Calgon Corp. (Pittsburgh, PA). When present, the optional preservative constituent should not exceed about 3%wt. of the skin treatment composition, although generally lesser amounts are usually effective.
The skin treatment compositions may include a fragrance constituent, which may be based on natural and synthetic fragrances and most commonly are mixtures or blends of a plurality of such fragrances, optionally in conjunction with a carrier such as an
organic solvent or a mixture of organic solvents in which the fragrances are dissolved, suspended or dispersed. When present in a such a composition, the fragrance constituent may be present in any effective amount such that it can be discerned by a consumer of the cleansing wipes, however is advantageously present in amounts of up to about 5%wt, preferably from about 0.00001%wt. to about 1.5%wt, most preferably from about
0.0001%wt. to 0.25%wt. based on the total weight of the skin treatment composition of which it forms a part.
The skin treatment compositions may include one or more colorants, e.g, dyes or pigments which are known to the art be useful in cosmetic or topical compositions which may be used to impart a desired color or tint to the inventive skin treatment compositions. When present, such colorants may be present in any effective amount such that it can be discerned by a consumer of the cleansing wipes, however is advantageously present in amounts of up to about 1.5%wt, preferably from about 0.00001%wt. to about 1.0%wt of Further optional constituents which may be advantageously included in the skin treatment composition is a pH adjusting agent, which may be used to adjust, and/or buffer the pH of the skin treatment composition. Essentially any material which may increase or decrease the pH of the skin treatment composition is suitable as a pH adjusting agent. Suitable pH adjusting agents are one or more acids and/or bases whether such be based on organic and/or inorganic compounds or materials. By way of non-limiting example, pH adjusting agents include phosphorus containing compounds, monovalent and polyvalent salts such as of silicates, carbonates, and borates, certain acids and bases, tartrates and certain acetates. Further exemplary pH adjusting agents include mineral acids, basic compositions, and organic acids, which are typically required in only minor amounts. Further exemplary and useful pH adjusting agents include monoalkanolamines, dialkanolamines, trialkanolamines, and alkylalkanolamines such as alkyl- dialkanolamines, and dialkyl-monoalkanolamines. Such may also function as detersive surfactants. The alkanol and alkyl groups are generally short to medium chain length, that is, from 1 to 7 carbons in length. By way of further non-limiting example, pH buffering agents also include the alkali metal phosphates, polyphosphates,
pyrophosphates, triphosphates, tetraphosphates, silicates, metasilicates, polysilicates, carbonates, hydroxides, and mixtures of the same. Certain salts, such as the alkaline
earth phosphates, carbonates, hydroxides, can also function as buffers. It may also be suitable to use as buffers such materials as aluminosilicates (zeolites), borates, aluminates and certain organic materials such as gluconates, succinates, maleates, citrates, and their alkali metal salts. It is to be noted that certain of the pH adjusting agents may also provide a chelating benefit as well.
When present, the one or more optional pH adjusting agents/pH buffers are included in amounts which are effective in establishing and/or maintaining the pH of a skin treatment composition at or within a desired pH value or range of pH values.
Preferably the pH of the skin treatment composition is in the range of 4 - 9.5.
Advantageously the one or more pH adjusting agents, comprise from about 0.001 - 2.5%wt, preferably from about 0.01 - 1.5%wt. of the skin treatment composition of which the one or more pH adjusting agents form a part.
A further optional constituent of the invention is a fragrance. Fragrances may be based on natural and synthetic fragrances and most commonly are mixtures or blends of a plurality of such fragrances, optionally in conjunction with a carrier such as an organic solvent or a mixture of organic solvents in which the fragrances are dissolved, suspended or dispersed. When present in a composition, the fragrance constituent may be present in any effective amount such that it can be discerned by a consumer of the cleansing wipe, however is advantageously present in amounts of up to about 5%wt, preferably from about 0.00001%wt. to about 1.5%wt. of the skin treatment composition.
Optionally the skin treatment composition may further include one or more skin benefit agents which may be used to promote an improved skin feel, or to improve skin health or appearance. Such include but are not limited to lipids such as cholesterol, ceramides, and pseudoceramides; sunscreens such as cinnamates; exfoliant particles such as polyethylene beads, walnut shells, apricot seeds, flower petals and seeds, and inorganics such as silica, and pumice; additional emollients (skin softening agents) such as long chain alcohols and waxes e.g., lanolin; additional moisturizers; skin-toning agents; skin nutrients such as vitamins like Vitamin C, D and E and essential oils like bergamot, citrus unshiu, calamus, and the like; water soluble or insoluble extracts of avocado, grape, grape seed, myrrh, cucumber, watercress, calendula, elder flower, geranium, linden blossom, amaranth, seaweed, gingko, ginseng, carrot; impatiens
balsamina, camu camu, alpine leaf and other plant extracts such as witch-hazel, and mixtures thereof, which may be provided to provide a fragrance, an aromatherapy or other benefit to users of the cleansing wipe. When present, such skin benefit agents may be included in effective amounts, and generally if present are not required amounts in excess of about 5%wt. based on the total weight of the skin treatment composition of which it forms a part.
In particularly preferred embodiments, the skin treatment composition necessarily essentially excludes volatile organic solvents, particularly one or more organic solvents selected from: monohydric alcohols, particularly Ci-C6 monohydric alcohols, especially methanol, ethanol, and the various isomers of propanol and butanol, as well as other volatile organic solvents having a boiling point of up to 120°C at 760 mm Hg (= 1 atmosphere). In the context of the present application, materials identified as examples of humectants, or as carriers for fragrances, essential oils or other optional constituents are not considered to fall within the class of excluded organic solvents. Thus,
"essentially excludes volatile organic solvents" is to be understood as meaning that the skin treatment compositions include not more than 0.5%wt, and in order of increasing preference, not more than 0.4%, 0.3%, 0.25%, 0.2% 0.15% 0.1%, 0.09%, 0.08%, 0.07%, 0.06%, 0.05%, 0.04%, 0.03%, 0.025%, 0.02%, 0.01%, 0.005%, 0.001%, and especially not more than 0% of said volatile organic solvents.
In the manufacture of the cleaning wipe articles of the invention, the skin treatment compositions are absorbed and/or absorbed onto a dry wipe substrate, and thereafter, a major proportion the water present in the skin treatment compositions is withdrawn, such as by evaporation, gentle heating, suction, or other operation, thereby retaining the remaining constituents having a vapor pressure greater than that of the water, at the conditions at which the water is withdrawn, absorbed/absorbed upon or within the substrate. A dry wipe substrate preferably has a moisture content of less than 10% wt, more preferably less than 5%wt, prior to the application of the skin treatment compositions thereto. Preferably during manufacture, after application of the skin treatment composition to a dry wipe, at least about 75%, and in order of increasing preference, at least about 80%,, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%,
91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 99.5%, 99.5% of the water initially present in the skin treatment composition is removed.
In a preferred embodiment, where the substrate is a substantially planar woven or nonwoven sheet or wipe, the relative mass of the foregoing skin treatment composition prior to the removal of a major proportion ( e.g. >90%, more preferably > 95%) of the water is about 0.5 - 20 grams (preferably about 5 grams) per gram of dry wipe substrate to which the skin treatment composition is applied. In a further preferred embodiment, following the removal of a major proportion ( e.g. >90%, more preferably > 95%) of the water initially present in the skin treatment composition, the skin treatment compositions is about 0.015 - 0.75 grams, preferably 2 - 5.5 grams of the treatment composition per gram of the dry wipe substrate.
Examples of suitable substrates include, without limitation: sponges, wipe articles, towels, cloths, pads and the like. Wipe articles can be of a woven or non-woven nature. Fabric substrates can include nonwoven or woven pouches, sponges, in the form of abrasive or non-abrasive cleaning pads. Such fabrics are known commercially in this field, and are generally substantially planar. Frequently, individual pieces of such fabrics are often referred to as wipes. Generally, such wipe articles are substantially planar in configuration, and have a thickness which is much less (generally at least 10 times less, preferably at least 100 times less) then the length and/or width of the wipe article. As such, such generally planar wipe articles are typically considered to be substantially "two-dimensional" type articles. Commonly such wipes may be provided as individual sheets which are provided as an individual article, or a plurality of folded wipes, or as a web of individual separable wipes joined at regions or lines of perforations and supplied upon a roll and whereby, an individual wipe can be separated from the roll by tearing along such a line of perforations. Such wipes can be resin bonded, hydroentanged, thermally bonded, meltblown, needlepunched or any combination of the former.
Nonwoven fabrics may be a combination of wood pulp fibers and textile length synthetic fibers formed by well known dry-form or wet-lay processes. Synthetic fibers such as rayon, nylon, orlon and polyester as well as blends thereof can be employed. The wood pulp fibers should comprise about 30 to about 60 percent by weight of the
nonwoven fabric, preferably about 55 to about 60 percent by weight, the remainder being synthetic fibers. The wood pulp fibers provide for absorbency, abrasion and soil retention whereas the synthetic fibers provide for substrate strength and resiliency.
Surprisingly the cleansing wipe articles of the invention initially appear to be substantially dry to the touch when provided to the consumer and thereby, the undesirable initial "slimy" feel prevalent among many known-art consumer products is avoided. Additionally, as the wipe articles in the invention can be used to provide a useful skin treatment benefit using little, or no water added to the wipe article and/or applied to a hands or other dermal surfaces to which the wipe article is thereafter contacted, such provides for a much greater degree of control by the consumer utilizing the cleaning wipe article of the delivery of the skin treatment composition. Such is advantageous particularly where a source of available water to subsequently used to rinse the hand or other dermal surfaces is unavailable, or available only in limited quantities. Further, it is observed that following the removal of the majority of the water from the initial skin treatment composition after it has been applied to a substrate (preferably, a sheet or wipe article), that the resultant cleansing wipes retain a smooth, slightly damp tactile feel and may be used even in the absence of additional water, or rinse water. Advantageously however, a small amounts, or even greater amount of water is applied to wets the hands, or other dermal surfaces prior to, but preferably during the use of the cleansing wipe article in order to express a satisfactory amount of foam or lather on to the treated dermal surfaces. Additionally, such also aids in the release of the antimicrobially effective amount of an organic acid from the cleansing wipe, and thereby an effective
antimicrobial effect is imparted to the treated dermal surfaces.
The wipe articles may be used to provide a treatment benefit to a human or other mammalian body, preferably hands, face, and/or other parts of the human body, e.g, epidermis, and hair.. Such treatment benefits include one or more of: a cleaning benefit, topical application of the skin treatment composition provided by the wipe article to a dermal surface and/or hair, and/or an antimicrobial benefit.
A further aspect of the invention is a method for providing a cleaning and/or providing an germicidal benefit to skin or other topical surface which method
contemplates the topical application of the a skin treatment composition via a wipe article
as described herein in a cleaning and/or germicidally effective amount. Preferably according to the foregoing method, a germicidal benefit is provided to the skin or other topical surface to which has been applied a treatment composition present upon on within a wipe article or other substrate. Preferred embodiments of the largely aqueous topical antimicrobial cleaning compositions exhibit good germicidal efficacy of undesired microorganisms, such as gram positive and/or gram negative bacterial, e.g., S.aureus, E.coli, P.auruginosa, as well as E.hirae on dermal (viz., skin, body) surfaces.
Cleansing wipes according to the invention can be produced by first producing a suitable quantity of a skin treatment composition, which is thereafter applied to a suitable substrate, most preferably a wipe to thereafter absorb, and/or adsorb the skin treatment composition within and/or upon said wipe. Advantageously, a role of a substrate is used to produce a plurality of wipes simultaneously. The use of a roll substrate also provides for use of known equipment, processes whereby the liquid skin treatment composition is introduced to the wipe substrate. For example a quantity of the skin treatment composition can be applied by spraying, dipping, padding, rolling, partially immersing, or holy immersing the wipe substrate within the skin treatment composition. Optionally, but may cases preferably, a series of pinch rollers can be used to squeeze the thus treated wipes substrate, in order to limit the amount of the liquid skin treatment composition absorbed and/or absorbed. Thereafter, a major portion of the water is removed, and such is most advantageously inconveniently performed by passing the treated substrate over one or more heated rollers whereby the substrate is in contact for a sufficient amount of time whereby at least 75%wt, preferably, at least 80%, and more preferably about 85%wt. of the water present in the skin treatment compositions is withdrawn or removed, such as by evaporation. Removal of the water can be further facilitated by including auxiliary equipment which may be fans, blowers, which may optionally provide further air streams to the wipe substrate being treated, in order to accelerate the removal of water. The wipe substrate having absorbed or adsorbed liquid skin treatment
composition can also be subjected to reduced pressure, such as a partial vacuum, under which conditions the removal of the water can be facilitated. Any combination of such manufacturing processes and/or conditions may be used.
Following the removal of water, advantageously the skin treatment composition of the cleansing wipe article (product) comprises (or consists essentially of, or consists of) :
25 - 70%wt, preferably 44 - 50%wt. of an anionic surfactant and/or a soap;
7 - 22% wt, preferably 12 - 20% wt. of a betaine surfactant;
0.6 - 1.7%wt, preferably 0.9 - 1.25%wt. of at least one Polyquaternium material selected from Polyquaternium 7, and/or Polyquaternium 10;
5.7 - 17.2%wt, preferably 9.5 - 13.2%wt of an antimicrobially effective amount of an organic acid;
5.7 - 17.2%w , preferably 9.5 - 13.2%w of a humectant;
0.25 - 0.85%wt, preferably 0.48 - 0.65%wt. of a chelating agent;
0 - 0.5%wt. of of one or more further compositions, constituents are compounds which provide a further technical and/or aesthetic benefits to the composition,
q.s., water, preferably less than 0.5%wt. water,
the said composition having a pH in the range of 4 - 9, and
wherein the relative mass of the foregoing composition is 0.015 - 0.75 grams, preferably 0.12 - 0.175 grams per gram of dry wipe substrate, and/or 0.5 - 25 grams, preferably 2 - 5.5 grams of the foregoing composition per square meter of a wipe substrate.
One or more cleansing wipe articles may be provided in a suitable package, or the cleansing wipes can be used individually without a package. When provided in a suitable package, a single cleansing wipe or a plurality of cleansing wipes may be provided, and such one or more wipes can be withdrawn as desired by a consumer or other ultimate user from the package and ultimately used to treat a dermal surface. The package may be a single use package, such as a pouch's physical integrity is destroyed upon opening, or may be a resealable package, or by following the removal of one or more wipes, package can be resealed to isolate the remaining cleansing wipes within the package from the surrounding environment. Such packaged cleansing wipe articles provide embodiments of the vendible articles of the invention.
The following examples below illustrate exemplary embodiments of the invention. It is to be understood that these examples are provided by way of illustration
only and that further useful embodiments of the invention falling within the scope of the description of the present invention and the claims may be readily produced by one of ordinary skill in the art without deviating from the scope and spirit of the invention.
Examples:
Example compositions according to the invention are identified on Table 1. The identified constituents were used "as supplied" from their respective suppliers, which are identified on Table 1, and may have constitute less than 100%wt. "actives" or may have been supplied constituting 100% wt. "active" of the named compound, as indicated below.
The identity of the constituents of Table 1 are more fully disclosed on the following Table 2:
Polyquaternium-7 polymeric quaternary ammonium salt of
acrylamide and dimethyl diallyl ammonium chloride, supplied as Mackernium 007 ( %wt. actives) (ex. Mclntyre Group)
citric acid (anhydrous) technical grade, anhydrous citric acid (100%wt.
actives)
tetrasodium EDTA (87%) aqueous solution/dispersion of technical or
laboratory grade tetrasodium
ethylenediaminetetraacetic acid (87%wt. actives) fragrance used as supplied, proprietary composition of its supplier
preservative methylchloroisothiazolinone/methylisothiazolinone soft water soft water (deionized, demineralized)
Cleansing wipes were produced by applying 8.03 grams of the composition described on Table 1 to a dry wipe nonwoven substrate material ("N Grade #180710, ex. Ahlstrom Co.) at an initial loading of 8.03 grams the skin treatment composition was applied to the said dry wipe substrate, yielding 160.5 grams the skin treatment composition per square meter of wipe substrate. Thereafter the thus treated substrate was subjected to a drying process, wherein either the substrate loaded with the skin treatment composition is allowed to air dry to remove most of the water initially present, or the thus treated substrate passes over or under a drying station, e.g, one or more heated rollers which induce the removal of most of the water initially present, or other processing equipment, e.g, infrared heaters, microwave heaters, which are similarly effective in removing most of the water initially present in the skin treatment composition loaded onto the dry wipe nonwoven substrate material. In this process, approximately 97%wt. of the water initially present in the composition described on Table 1 was removed. The resultant composition of the skin treatment composition present in the wipe article was as follows:
46.55%wt. sodium lauryl ether sulfate (70%)
15.9%wt. cocoamidopropyl betaine (29%)
11.47% wt. salicylic acid
11.47% wt. glycerine
1.14%wt Polyquaternium-7
0.34%wt citric acid (anhydrous)
0.57%wt tetrasodium EDTA (87%)
11.47%wt fragrance
0.013%wt preservative
> 0.05%wt soft water
wherein the relative mass of the foregoing composition was present at a loading of 4.97 grams per gram of the dry wipe substrate.
The thus manufactured cleansing wipe articles may be retained in a continuous roll form, or may be perforated at one or more regions thereof, or may be cut into individual sheets which facilitate their use. The cleansing wipe articles may optionally but preferably be packaged so that a plurality of wipe articles are provided in a container as a vendible product, which allows for one or more of the wipe articles to be withdrawn from the package and used, as desired by a consumer.
The manufactured cleansing wipe articles were tested by rinsing with a small amount of water to wet the article, and thereafter the wipe article was applied to the hands in a wiping manner to release the constituents of the resultant skin treatment composition onto the skin to provide a cleaning benefit thereto. The cleansing wipe articles initially appeared to be substantially dry to the touch and did not have an initial "slimy" feel. Good foaming and effective cleaning of the hands was observed when used.
Claims
Claims: 1. A cleansing wipe article having adsorbed thereon and/or absorbed within a wipe substrate a skin treatment composition which comprises (or consists essentially of, or consists of) a composition which includes:
0.01 - 7%wt. of an anionic surfactant and/or a soap;
0.1 - 7%wt. of a betaine surfactant;
0.01 - 2%wt. of a Polyquaternium material selected from Polyquaternium 7, and/or Polyquaternium 10;
0.01 - 0.4%wt. of an antimicrobially effective amount of an organic acid;
0.01 - 2%wt. of a humectant;
0.01 - 0.5%wt. of a chelating agent;
0 - 25%wt. of one or more further compositions, constituents are compounds which provide a further technical and/or aesthetic benefits to the soap bars,
q.s., water,
which foregoing skin treatment composition is absorbed or adsorbed into or onto the wipe substrate, wherein the relative mass of the skin treatment composition is about 0.5 - 20 grams (preferably about 5 grams) per gram of dry wipe substrate, and/or is about 15 - 650 grams (preferably about 160 grams) of the skin treatment composition per square meter of the wipe substrate.
2. A cleansing wipe article having adsorbed thereon and/or absorbed within a wipe substrate said wipe a skin treatment which comprises (or consists essentially of, or consists of) :
25 - 70%wt, preferably 44 - 50%wt. of an anionic surfactant and/or a soap;
7 - 22%wt, preferably 12 - 20% wt. of a betaine surfactant;
0.6 - 1.7%wt, preferably 0.9 - 1.25%wt. of at least one Polyquaternium material selected from Polyquaternium 7, and/or Polyquaternium 10;
5.7 - 17.2%wt, preferably 9.5 - 13.2%wt of an antimicrobially effective amount of an organic acid;
5.7 - 17.2%wt, preferably 9.5 - 13.2%wt. of a humectant;
0.25 - 0.85%wt., preferably 0.48 - 0.65%wt. of a chelating agent;
0 - 0.5%wt. of of one or more further compositions, constituents are compounds which provide a further technical and/or aesthetic benefits to the composition,
q.s., water, preferably less than 0.5%wt. water,
the said composition having a pH in the range of 4 - 9, and
wherein the relative mass of the foregoing composition is 0.015 - 0.75 grams, preferably 0.12 - 0.175 grams per gram of dry wipe substrate, and/or 0.5 - 25 grams, preferably 2 - 5.5 grams of the foregoing composition per square meter of a wipe substrate.
3. A method of manufacturing a cleansing wipe article, the method comprising the steps of:
forming a skin treatment composition which comprises (or consists essentially of, or consists of) a composition which includes:
0.01 - 7%wt. of an anionic surfactant and/or a soap;
0.1 - 7%wt. of a betaine surfactant;
0.01 - 2%wt. of a Polyquaternium material selected from Polyquaternium 7, and/or Polyquaternium 10;
0.01 - 0.
4%wt. of an antimicrobially effective amount of an organic acid;
0.01 - 2%wt. of a humectant;
0.01 - 0.5%wt. of a chelating agent;
0 - 25%wt. of one or more further compositions, constituents are compounds which provide a further technical and/or aesthetic benefits to the soap bars,
q.s., water,
absorbing or adsorbing the foregoing skin treatment composition into or onto a dry wipe substrate at a relative mass of the skin treatment composition of 0.5 - 20 grams (preferably about 5 grams) per gram of dry wipe substrate, and/or of 15 - 650 grams
(preferably about 160 grams) of the skin treatment composition per square meter of the wipe substrate;
drying the substrate to remove a major proportion of the water initially present in the foregoing skin treatment composition, to provide a cleansing wipe article product having adsorbed thereon and/or absorbed within a wipe substrate said wipe a skin treatment which comprises (or consists essentially of, or consists of) :
25 - 70%wt, preferably 44 - 50%wt. of an anionic surfactant and/or a soap; 7 - 22% wt, preferably 12 - 20% wt. of a betaine surfactant;
0.6 - 1.7%wt, preferably 0.9 - 1.25%wt. of at least one Polyquaternium material selected from Polyquaternium 7, and/or Polyquaternium 10;
5.7 - 17.2%wt, preferably 9.5 - 13.2%wt of an antimicrobially effective amount of an organic acid;
5.7 - 17.2%wt, preferably 9.5 - 13.2%wt. of a humectant;
0.25 - 0.85%wt, preferably 0.48 - 0.65%wt. of a chelating agent;
0 - 0.5%wt. of of one or more further compositions, constituents are compounds which provide a further technical and/or aesthetic benefits to the composition,
q.s., water, preferably less than 0.5%wt. water,
the said composition having a pH in the range of 4 - 9, and
wherein the relative mass of the foregoing composition is 0.015 - 0.75 grams, preferably 0.12 - 0.175 grams per gram the dry wipe substrate, and/or 0.5 - 25 grams, preferably 2 - 5.5 grams of the foregoing composition per square meter of a wipe substrate.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1314690.7A GB201314690D0 (en) | 2013-08-16 | 2013-08-16 | Cleansing wipes |
PCT/GB2014/052388 WO2015022495A1 (en) | 2013-08-16 | 2014-08-04 | Cleansing wipes |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3033069A1 true EP3033069A1 (en) | 2016-06-22 |
Family
ID=49301812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14749997.4A Withdrawn EP3033069A1 (en) | 2013-08-16 | 2014-08-04 | Cleansing wipes |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3033069A1 (en) |
AU (1) | AU2014307793A1 (en) |
GB (1) | GB201314690D0 (en) |
MX (1) | MX2016001818A (en) |
WO (1) | WO2015022495A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3051670B1 (en) * | 2016-05-31 | 2018-06-29 | L'oreal | FOAMING CLEANSING COMPOSITION |
CN107377669A (en) * | 2017-08-28 | 2017-11-24 | 天津隆恒预应力钢绞线有限公司 | A kind of wire rod surface cleaning device and its technique |
US20220370339A1 (en) * | 2019-06-09 | 2022-11-24 | LaShondria Camp | Scalp cleansing wipes and treatment formulation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE550010T1 (en) * | 1997-09-05 | 2012-04-15 | Procter & Gamble | PREPARATIONS FOR CLEANSING AND CONDITIONING SKIN AND HAIR WITH IMPROVED DEPOSITION OF CONDITIONING INGREDIENTS |
US6413529B1 (en) * | 1999-04-13 | 2002-07-02 | The Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria |
US6482423B1 (en) * | 1999-04-13 | 2002-11-19 | The Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus gram positive bacteria |
US20030199404A1 (en) * | 2002-04-23 | 2003-10-23 | The Procter & Gamble Company | Hotmelt compositions and related articles |
US8877316B2 (en) * | 2002-12-20 | 2014-11-04 | The Procter & Gamble Company | Cloth-like personal care articles |
CA2658299C (en) * | 2006-07-31 | 2012-05-29 | The Procter & Gamble Company | Cleansing articles for skin or hair |
-
2013
- 2013-08-16 GB GBGB1314690.7A patent/GB201314690D0/en not_active Ceased
-
2014
- 2014-08-04 MX MX2016001818A patent/MX2016001818A/en unknown
- 2014-08-04 AU AU2014307793A patent/AU2014307793A1/en not_active Abandoned
- 2014-08-04 EP EP14749997.4A patent/EP3033069A1/en not_active Withdrawn
- 2014-08-04 WO PCT/GB2014/052388 patent/WO2015022495A1/en active Application Filing
Non-Patent Citations (2)
Title |
---|
None * |
See also references of WO2015022495A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU2014307793A1 (en) | 2016-03-03 |
GB201314690D0 (en) | 2013-10-02 |
WO2015022495A1 (en) | 2015-02-19 |
MX2016001818A (en) | 2016-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020257129B2 (en) | Treatment compositions providing an antimicrobial benefit | |
Mishra | Ester quats: the novel class of cationic fabric softeners | |
AU2008348976B2 (en) | Low residue cleaning solution | |
AU2013255556B2 (en) | Foaming formulations and cleansing products including silicone polyesters | |
JP2007077311A (en) | High detergency abrasive detergent | |
AU2003288220A1 (en) | Customized personal cleansing article | |
JP2004529148A (en) | Wet type antibacterial wipes | |
DE102009003027A1 (en) | Probiotic cleaner for hard surfaces | |
JP6972198B2 (en) | Pre-wet wipes for use in the treatment of anal and rectal inflammation and disorders | |
EP3033069A1 (en) | Cleansing wipes | |
WO2008119636A1 (en) | Textile fabric with cleaning capacity | |
CA3011975C (en) | Wet wipes containing hydroxy acetophenone and cocamidopropyl pg-dimonium chloride phosphate | |
JP2007191469A (en) | Wipe | |
JP6249404B2 (en) | Liquid deodorant disinfectant composition | |
JP2004204220A (en) | Product of liquid detergent for direct application | |
Overkempe et al. | Esterquats | |
KR20150087418A (en) | Aromatic substance mixtures containing hexyl salicylate | |
JP5830376B2 (en) | Liquid bleaching composition | |
JP5921831B2 (en) | Tobacco odor deodorant | |
JP2006160964A (en) | Polishing-agent containing detergent | |
EP4282944A1 (en) | Unit dose for personal care or household care composition | |
SU594165A1 (en) | Hand cleaning agent | |
JP2020050638A (en) | Skin cosmetic composition | |
HOLMBERG | MARIA STJERNDAHL, DAN LUNDBERG | |
US20040161290A1 (en) | Customized personal cleansing system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20160210 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20180710 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20181121 |